Innovotech Initiates Field Trials for Novel Seed Treatment, Agress(TM)
June 10 2008 - 11:55AM
Marketwired
EDMONTON, ALBERTA , in partnership with agricultural stations in
Alberta, Saskatchewan, and Manitoba, is pleased to announce the
initiation of summer field trials with its novel seed treatment,
Agress(TM). Innovotech is testing the efficacy of Agress(TM)
against multiple diseases on beans, peas, and soybeans to advance
its marketing plan and recent registration application with Health
Canada and the US Environmental Protection Agency.
"This is the next step to verify the efficacy of Agress(TM) in
real world conditions that a farmer might face, using multiple
locations across Canada to simulate variability of climate and soil
conditions. It is also the next step in expanding the disease and
crop scope for Agress(TM)," says Damian Sowa, Product Manager,
Innovotech. "Agress(TM) will break new ground in crop protection,
coupling environmental friendliness with broad spectrum
effectiveness at low rates of application."
Innovotech anticipates regulatory approval for Agress(TM) in
Canada and the United States mid- to late-2009, permitting sales
launch for the 2010 season. Research is currently underway to
expand the claims of Agress(TM) to the major crops in North America
and additional disease classes.
About Innovotech Inc:
Innovotech is a product development company focusing on the
development of solutions to medical, agricultural and industrial
problems caused by microbial biofilms. Biofilms are protected
communities of microorganisms which are very common and very
difficult to treat due to their inherent resistance. They have been
implicated in a host of devastating infections in agriculture,
human health and industry. No diagnostics or antibiotics are
currently approved for use in infections involving biofilms.
The TSX Venture Exchange does not accept responsibility for the
adequacy or accuracy of this release.
Contacts: Innovotech Inc. Wolfgang Muhs CEO (780) 448-0585 ext.
226 (780) 424-0941 (FAX) Email: wolfgang.muhs@innovotech.ca
Innovotech Inc. Ken Boutilier President (780) 448-0585 ext. 221
(780) 424-0941 (FAX) Email: ken.boutilier@innovotech.ca Website:
www.innovotech.ca
Innovotech (TSXV:IOT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Innovotech (TSXV:IOT)
Historical Stock Chart
From Jul 2023 to Jul 2024